Securian Asset Management, Inc Nektar Therapeutics Transaction History

Securian Asset Management, Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$10.83 - $18.41 $178,510 - $303,452	-16,483 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$13.07 - $18.84 $3,555 - $5,124	-272 Reduced 1.62%	16,483 $296,000
Q2 2021 Aug 10, 2021	SELL	$16.52 - $20.4 $7,219 - $8,914	-437 Reduced 2.54%	16,755 $288,000
Q1 2021 May 10, 2021	BUY	$16.56 - $25.46 $3,080 - $4,735	186 Added 1.09%	17,192 $344,000
Q4 2020 Feb 08, 2021	SELL	$15.77 - $19.03 $5,787 - $6,984	-367 Reduced 2.11%	17,006 $289,000
Q3 2020 Nov 04, 2020	SELL	$16.59 - $24.79 $9,738 - $14,551	-587 Reduced 3.27%	17,373 $288,000
Q2 2020 Aug 06, 2020	SELL	$16.86 - $23.44 $1,686 - $2,344	-100 Reduced 0.55%	17,960 $416,000
Q4 2019 Feb 04, 2020	BUY	$15.87 - $23.12 $3,507 - $5,109	221 Added 1.24%	18,060 $390,000
Q2 2019 Aug 05, 2019	BUY	$31.0 - $36.3 $7,812 - $9,147	252 Added 1.43%	17,839 $635,000
Q1 2019 Apr 26, 2019	BUY	$31.58 - $46.35 $4,926 - $7,230	156 Added 0.89%	17,587 $591,000
Q4 2018 Feb 04, 2019	SELL	$30.43 - $56.65 $10,011 - $18,637	-329 Reduced 1.85%	17,431 $573,000
Q3 2018 Oct 26, 2018	BUY	$46.46 - $68.49 $67,320 - $99,242	1,449 Added 8.88%	17,760 $1.08 Million
Q2 2018 Aug 09, 2018	SELL	$46.25 - $104.45 $9,250 - $20,890	-200 Reduced 1.21%	16,311 $796,000
Q1 2018 Apr 30, 2018	BUY	$57.4 - $108.44 $947,731 - $1.79 Million	16,511 New	16,511 $1.75 Million

146

140M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $157M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Securian Asset Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Securian Asset Management, Inc with notifications on news.